(-0.11%) 5 141.50 points
(-0.07%) 38 532 points
(-0.04%) 17 896 points
(0.08%) $82.70
(2.51%) $2.08
(-1.29%) $2 327.40
(-2.57%) $26.95
(-0.96%) $952.30
(0.18%) $0.934
(0.36%) $11.02
(0.20%) $0.798
(-0.12%) $93.19
Live Chart Being Loaded With Signals
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses...
Stats | |
---|---|
Šios dienos apimtis | 2.20M |
Vidutinė apimtis | 1.11M |
Rinkos kapitalizacija | 3 658.79B |
EPS | ¥0 ( 2024-04-29 ) |
Kita pelno data | ( ¥122.99 ) 2024-05-09 |
Last Dividend | ¥50.00 ( 2023-06-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 30.07 |
ATR14 | ¥12.75 (0.19%) |
Tūris Koreliacija
Otsuka Holdings Co., Ltd. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Otsuka Holdings Co., Ltd. Koreliacija - Valiuta/Žaliavos
Otsuka Holdings Co., Ltd. Finansinės ataskaitos
Annual | 2023 |
Pajamos: | ¥2 018.57B |
Bruto pelnas: | ¥1 407.35B (69.72 %) |
EPS: | ¥224.11 |
FY | 2023 |
Pajamos: | ¥2 018.57B |
Bruto pelnas: | ¥1 407.35B (69.72 %) |
EPS: | ¥224.11 |
FY | 2022 |
Pajamos: | ¥1 738.00B |
Bruto pelnas: | ¥1 168.50B (67.23 %) |
EPS: | ¥246.81 |
FY | 2021 |
Pajamos: | ¥1 498.28B |
Bruto pelnas: | ¥1 003.25B (66.96 %) |
EPS: | ¥231.35 |
Financial Reports:
No articles found.
Otsuka Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥50.00 (N/A) |
¥0 (N/A) |
¥50.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥28.00 | 2011-03-29 |
Last Dividend | ¥50.00 | 2023-06-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 27 | -- |
Total Paid Out | ¥1 121.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.9 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.35 | |
Div. Directional Score | 8.77 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8558.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7885.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7030.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6364.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
5261.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4331.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
3492.T | Ex Dividend Junior | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
2733.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9622.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
8159.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0602 | 1.500 | 8.80 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0362 | 1.200 | 8.79 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0508 | 1.500 | -0.547 | -0.821 | [0.1 - 1] |
payoutRatioTTM | 0.458 | -1.000 | 5.42 | -5.42 | [0 - 1] |
currentRatioTTM | 1.989 | 0.800 | 5.06 | 4.05 | [1 - 3] |
quickRatioTTM | 1.533 | 0.800 | 5.69 | 4.55 | [0.8 - 2.5] |
cashRatioTTM | 0.769 | 1.500 | 6.84 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0468 | -1.500 | 9.22 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 37.62 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 521.91 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 310.60 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0658 | -1.500 | 9.74 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.697 | 1.000 | 1.713 | 1.713 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.126 | 1.000 | 9.49 | 9.49 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.799 | 1.000 | 1.119 | 1.119 | [0.2 - 2] |
assetTurnoverTTM | 0.601 | 0.800 | 9.33 | 7.46 | [0.5 - 2] |
Total Score | 11.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 28.58 | 1.000 | 7.21 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0508 | 2.50 | -0.352 | -0.821 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 310.60 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.717 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 521.91 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.458 | 1.500 | 5.42 | -5.42 | [0 - 1] |
pegRatioTTM | 4.27 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.140 | 1.000 | 8.99 | 0 | [0.1 - 0.5] |
Total Score | 6.35 |
Otsuka Holdings Co., Ltd.
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.